2-112739003-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_152515.5(CKAP2L):āc.2058T>Cā(p.Pro686Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00103 in 1,614,232 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0056 ( 13 hom., cov: 32)
Exomes š: 0.00055 ( 8 hom. )
Consequence
CKAP2L
NM_152515.5 synonymous
NM_152515.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -6.84
Genes affected
CKAP2L (HGNC:26877): (cytoskeleton associated protein 2 like) The protein encoded by this gene is thought to be a mitotic spindle protein important to neural stem or progenitor cells. Mutations in this gene have been associated with spindle organization defects, including mitotic spindle defects, lagging chromosomes, and chromatin bridges. There is evidence that mutations in this gene are associated with Filippi syndrome, characterized by growth defects, microcephaly, intellectual disability, facial feature defects, and syndactyly. There is a pseudogene of this gene on chromosome 20. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015]
NT5DC4 (HGNC:27678): (5'-nucleotidase domain containing 4) Predicted to enable 5'-nucleotidase activity. Predicted to be involved in dephosphorylation. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 2-112739003-A-G is Benign according to our data. Variant chr2-112739003-A-G is described in ClinVar as [Benign]. Clinvar id is 719773.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00561 (855/152364) while in subpopulation AFR AF= 0.0195 (811/41590). AF 95% confidence interval is 0.0184. There are 13 homozygotes in gnomad4. There are 417 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 13 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CKAP2L | NM_152515.5 | c.2058T>C | p.Pro686Pro | synonymous_variant | 9/9 | ENST00000302450.11 | NP_689728.3 | |
NT5DC4 | NM_001393655.1 | c.*67A>G | 3_prime_UTR_variant | 17/17 | ENST00000688554.1 | NP_001380584.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CKAP2L | ENST00000302450.11 | c.2058T>C | p.Pro686Pro | synonymous_variant | 9/9 | 1 | NM_152515.5 | ENSP00000305204.6 | ||
NT5DC4 | ENST00000688554.1 | c.*67A>G | 3_prime_UTR_variant | 17/17 | NM_001393655.1 | ENSP00000509504.1 |
Frequencies
GnomAD3 genomes AF: 0.00560 AC: 852AN: 152246Hom.: 13 Cov.: 32
GnomAD3 genomes
AF:
AC:
852
AN:
152246
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00145 AC: 365AN: 251432Hom.: 2 AF XY: 0.000942 AC XY: 128AN XY: 135890
GnomAD3 exomes
AF:
AC:
365
AN:
251432
Hom.:
AF XY:
AC XY:
128
AN XY:
135890
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000553 AC: 808AN: 1461868Hom.: 8 Cov.: 31 AF XY: 0.000436 AC XY: 317AN XY: 727242
GnomAD4 exome
AF:
AC:
808
AN:
1461868
Hom.:
Cov.:
31
AF XY:
AC XY:
317
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00561 AC: 855AN: 152364Hom.: 13 Cov.: 32 AF XY: 0.00560 AC XY: 417AN XY: 74514
GnomAD4 genome
AF:
AC:
855
AN:
152364
Hom.:
Cov.:
32
AF XY:
AC XY:
417
AN XY:
74514
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at